Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $2.05 Million - $5.12 Million
-150,700 Reduced 80.93%
35,500 $569,000
Q4 2019

Feb 13, 2020

BUY
$16.12 - $24.98 $2.21 Million - $3.43 Million
137,200 Added 280.0%
186,200 $4.45 Million
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $682,080 - $1.1 Million
-58,800 Reduced 54.55%
49,000 $643,000
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $2.04 Million - $3.03 Million
107,800 New
107,800 $2.18 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.8B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.